Company Search:
Advanced Search
Sponsored Links
Nuevolution AB (publ) Company Snapshot
Nuevolution AB (publ) operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Nuevolution AB (publ) with three other pharmaceutical manufacturers in Europe: ExpreS2ion Biotech Holding AB (2018 sales of 8.87 million Swedish Kronor [US$904,003.92 ] ), Erytech Pharma SA of France (4.45 million Euro [US$4.91 million] of which 100% was Pharmacy), and Oncoarendi Therapeutics SA which is based in Poland (3,000.00 Polish New Zlotys [US$771.21 ] ).

Sales Analysis. During the year ended December of 2018, sales at Nuevolution AB (publ) were SEK 10.97 million (US$1.12 million). This is an increase of 13.7% versus 2017, when the company's sales were SEK 9.65 million. Despite this increase, sales are still well below the level achieved in 2016, when Nuevolution AB (publ) reported sales of SEK 21.31 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Nuevolution AB (publ)
  Stock Performance Chart for Nuevolution AB (publ)
  Stock Data: Recent Stock Performance:
  Current Price (7/26/2019): 32.40
(Figures in Swedish Kronor)
1 Week -0.3%   13 Weeks 0.3%  
4 Weeks 156.1%   52 Weeks 90.4%  
Nuevolution AB (publ) Key Data:
  Ticker: NUE Country: Denmark
  Exchanges: STO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2018 Sales 10,973,000
(Year Ending Jan 2019).
Employees: 49
  Currency: Swedish Kronor Market Cap: 1,604,610,000
  Fiscal Yr Ends: December Shares Outstanding: 49,525,000
  Share Type: Aktie Closely Held Shares: 4,472,334
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.